CSF2 and neoplasm: The induction of anti-tumour immunity by vaccination with irradiated GM-CSF expressing tumour cells had been explored preclinically in animal models for other cancers including melanoma and prostate cancer [26,27] and a pancreas-specific vaccine entered several clinical trials for evaluation of safety and efficacy.